However, given the evidence suggesting its involvement in anti-inflammatory and neuroprotective mechanisms in a number of murine autoimmune disease models [31], it is still debatable whether therapeutic inhibition of IFN-γ pathways would help counteract the progression of AMD. The gene discussed is IFNG; the disease is age-related macular degeneration.